ABTERRA BIOSCIENCES, INC.
Last verified 2026-05-05. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $1.9Mattributed |
|---|---|
| Latest round | grant, $1.9M, 2024-09-01attributed |
| Founded | 2014 |
| Headquarters | SAN DIEGO, California, USA |
| Industry | ai |
| Stage | unknown |
| Website | abterrabio.com |
Abterra Bio combines next-generation sequencing, mass spectrometry, and machine learning to map the antibody response and find better therapeutic antibodies. It serves research institutions, biotech, and pharma teams needing antibody discovery and protein sequencing. Its species-agnostic platform delivers fully characterized recombinant antibodies without needing B cells.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2024-09-01 | grant | $1.9M | undisclosed |
Detected tech stack
PHP 8.1.34, WordPress 6.9.4, Apache HTTP Server, Yoast SEO 27.4, Yoast SEO Premium 27.4, Google Tag Manager, FitVids.JS 1754597860, jQuery Migrate 3.4.1, jQuery Mobile, MySQL, jquery 3.7.1, apache
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $1.9M | attributed | sbir named as publisher. No document URL on file. |
| Total raised $1.9M | attributed | sbir named as publisher. No document URL on file. |
| Company existence | self-reported | abterrabio.com, read 2026-05-05 |
| Description | self-reported | abterrabio.com, read 2026-05-05 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.